USD 15.75
(-6.8%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 67.84 Million | 83.73 Million | -28.27 Million | -4.85 Million | 18.16 Million | 30.6 Million |
Net Income | 23.91 Million | 33.31 Million | 28.84 Million | 13.12 Million | 16.75 Million | 14.25 Million |
Depreciation & Amortization | 1.33 Million | 1.36 Million | 1.31 Million | 1.3 Million | 1.14 Million | 1.04 Million |
Deferred income taxes | 626 Thousand | 1.08 Million | -2.31 Million | - | - | - |
Stock-based compensation | 1.29 Million | 1.17 Million | 558 Thousand | 1.1 Million | 1.27 Million | 969 Thousand |
Change in working capital | -2.59 Million | -3.57 Million | 8.68 Million | -1.73 Million | 673 Thousand | -1.66 Million |
Other non-cash items | 50.78 Million | 62.79 Million | -51.24 Million | -17.09 Million | 3 Million | 19.34 Million |
Investing Cash Flow | -75.97 Million | -461.77 Million | -286.04 Million | -147.06 Million | -117.4 Million | -146.28 Million |
Investments in PPE | -2.18 Million | -1.41 Million | -1.12 Million | -619 Thousand | -1.73 Million | -1.19 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -8.57 Million | -116.94 Million | -99.19 Million | -66.61 Million | -16.74 Million | -23.84 Million |
Sales/Maturities of investments | 24.36 Million | 32.19 Million | 35.94 Million | 30.32 Million | 14.54 Million | 6.56 Million |
Other Investing Activities | -4.04 Million | -11.47 Million | -963 Thousand | -685 Thousand | 2.28 Million | - |
Financing Cash Flow | 16.37 Million | 345.55 Million | 323.47 Million | 172.28 Million | 107.55 Million | 130.15 Million |
Debt repayment | -105 Million | - | -5 Million | 5 Million | - | - |
Dividends payments | -7.26 Million | -6.67 Million | -5.13 Million | -4.26 Million | -3.15 Million | - |
Common Stock Repurchased | -3.93 Million | - | -28 Thousand | -8.1 Million | -5.39 Million | - |
Common Stock Issuance | 888 Thousand | - | - | - | - | 22.56 Million |
Other Financing Activities | -98 Thousand | -81 Thousand | -434 Thousand | -107 Thousand | - | - |
Accounts receivables | -1.07 Million | -2.39 Million | 242 Thousand | -1.46 Million | -98 Thousand | -605 Thousand |
Accounts payables | 9.85 Million | 2.21 Million | -463 Thousand | -1.66 Million | 971 Thousand | 1.29 Million |
Inventory | - | - | - | - | - | - |
Other working capital | -1.51 Million | - | - | - | - | - |
Cash at beginning of period | 82.97 Million | 115.45 Million | 106.31 Million | 85.94 Million | 77.72 Million | 63.25 Million |
Cash at end of period | 91.21 Million | 82.97 Million | 115.45 Million | 106.31 Million | 86.03 Million | 77.72 Million |
Capital Expenditure | -2.18 Million | -1.41 Million | -1.12 Million | -619 Thousand | -1.73 Million | -1.19 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 8.24 Million | -32.48 Million | 9.14 Million | 20.36 Million | - | - |
Free Cash Flow | 65.65 Million | 82.32 Million | -29.4 Million | -5.47 Million | 16.42 Million | 29.41 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 5.43 Million | 5.22 Million | 23.44 Million | 5.17 Million | 5.12 Million | 6.09 Million |
Depreciation & Amortization | 332 Thousand | 367 Thousand | 1.33 Million | 361 Thousand | 302 Thousand | 339 Thousand |
Deferred income taxes | -263 Thousand | 54 Thousand | 626 Thousand | - | - | -606 Thousand |
Stock-based compensation | 317 Thousand | 319 Thousand | 1.29 Million | 336 Thousand | 323 Thousand | 314 Thousand |
Change in working capital | -324 Thousand | 4.89 Million | -2.59 Million | -6.18 Million | 9.21 Million | -5.21 Million |
Other non-cash items | 12.11 Million | -12.4 Million | -3.24 Million | 229 Thousand | 1.74 Million | 9.72 Million |
Investing Cash Flow | -78.68 Million | -34.52 Million | -28.98 Million | -2.42 Million | -37.31 Million | -22.36 Million |
Investments in PPE | -77 Thousand | -90 Thousand | -2.18 Million | -231 Thousand | -587 Thousand | -785 Thousand |
Acquisitions | - | - | 52.01 Million | - | - | - |
Investment purchases | -20.62 Million | -1.06 Million | -8.57 Million | -1.3 Million | -24 Thousand | -1.46 Million |
Sales/Maturities of investments | 6.9 Million | 5.14 Million | 24.36 Million | 5.48 Million | 6.27 Million | 6.89 Million |
Other Investing Activities | -53.72 Million | - | -94.6 Million | -1000.00 | - | - |
Financing Cash Flow | 51.29 Million | 85.7 Million | 16.37 Million | -10.76 Million | -16.12 Million | -24.08 Million |
Debt repayment | -10 Million | - | -105 Million | 10 Million | 20 Million | 25 Million |
Dividends payments | -1.78 Million | -1.8 Million | -7.26 Million | -1.8 Million | -1.81 Million | -1.82 Million |
Common Stock Repurchased | -2.2 Million | -483 Thousand | -3.93 Million | -1.35 Million | - | -2.01 Million |
Common Stock Issuance | - | - | 888 Thousand | - | - | - |
Other Financing Activities | -116 Thousand | -21 Thousand | -98 Thousand | - | -14 Thousand | -73 Thousand |
Accounts receivables | -185 Thousand | -111 Thousand | -1.07 Million | -263 Thousand | -293 Thousand | -401 Thousand |
Accounts payables | 3.23 Million | -358 Thousand | 9.85 Million | -924 Thousand | 4.19 Million | 3.6 Million |
Inventory | - | - | - | - | - | - |
Other working capital | -324 Thousand | - | -11.37 Million | - | - | - |
Cash at beginning of period | 139.24 Million | 91.21 Million | 82.97 Million | 105.74 Million | 143.76 Million | 181.5 Million |
Cash at end of period | 127.67 Million | 139.24 Million | 91.21 Million | 91.21 Million | 105.74 Million | 143.76 Million |
Capital Expenditure | -77 Thousand | -90 Thousand | -2.18 Million | -231 Thousand | -587 Thousand | -785 Thousand |
Effect of forex changes on cash | - | - | -27.57 Million | - | - | - |
Net cash flow / Change in cash | -11.57 Million | 48.03 Million | 8.24 Million | -14.52 Million | -38.02 Million | -37.74 Million |
Free Cash Flow | 15.73 Million | -3.24 Million | 18.67 Million | -1.56 Million | 14.83 Million | 7.92 Million |
QOMOU
JOBY-WT
QAMC
601018
VZZ
AGYP